Depression in Alzheimer's disease

Expert Review of Neurotherapeutics

Volumn 6, Issue 6, 2006, Pages 887-895

  Starkstein, Sergio E ^a   Mizrahi, Romina ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Alzheimer's disease; Dementia; Depression; Treatment

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; IMIPRAMINE; MAPROTILINE; MOCLOBEMIDE; PAROXETINE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ALZHEIMER DISEASE; BLURRED VISION; CLINICAL FEATURE; CONSTIPATION; DEPRESSION; DIZZINESS; ELECTROCONVULSIVE THERAPY; HAMILTON SCALE; HEADACHE; HUMAN; MYOCLONUS; PREVALENCE; PSYCHOTHERAPY; REVIEW;

ALZHEIMER DISEASE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSION; ELECTROSHOCK; HUMANS; MONOAMINE OXIDASE INHIBITORS; PREVALENCE; PSYCHOTHERAPY; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 33745505543     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.6.6.887     Document Type: Review

References (49)

1. Payne JL, Sheppard JM, Steinberg M, Warren A, Baker A, Steele C. Incidence, prevalence, and outcomes of depression in residents of a long-term care facility with dementia. Int. J. Geriatr. Psychiatry 17(3), 247-253 (2002).
2. Cummings JL. The impact of depressive symptoms on patients with Alzheimer disease. Alzheimer. Dis. Assoc. Disord. 17, 61-62 (2003).
3. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 288(12), 1475-1483 (2002).
4. Lee HB, Lyketsos CG. Depression in Alzheimer's disease: heterogeneity and related issues. Biol. Psych. 54(3), 353-362 (2003).
5. Kales HC, Chen P, Blow FC, Welsh DE, Mellow AM. Rates of clinical depression diagnosis, functional impairment, and nursing home placement in coexisting dementia and depression. Am. J. Geriatr. Psychiatry 13, 441-449 (2005).
6. Cohen CI, Hyland K, Kimhy D. The utility of mandatory depression screening of dementia patients in nursing homes. Am. J. Psych. 160, 2012-2017 (2003).
7. Lyketsos CG, Olin J. Depression in Alzheimer's disease: overview and treatment. Biol. Psych. 52(3), 243-252 (2002).
8. Gallo JJ, Rabins PV, Anthony JC. Sadness in older persons: 13-year follow-up of a community sample in Baltimore, Maryland. Psychol. Med. 29(2), 341-350 (1999).
9. Gallo JJ, Rabins PV, Lyketsos CG, Tien AY, Anthony JC. Depression without sadness: functional outcomes of nondysphoric depression in later life. J. Am. Geriatr. Soc. 45(5), 570-578 (1997).
10. Olin JT, Katz IR, Meyers BS, Schneider LS, Lebowitz BD. Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background. Am. J. Geriatr. Psychiatry 10(2), 129-141 (2002).
11. Chemerinski E, Petracca G, Sabe L, Kremer J, Starkstein SE. The specificity of depressive symptoms in patients with Alzheimer's disease. Am. J. Psych. 158(1), 68-72 (2001).
12. Loewenstein DA, Arguelles S, Bravo M, Freeman RQ, Arguelles T, Acevedo A. Caregivers' judgments of the functional abilities of the Alzheimer's disease patient: a comparison of proxy reports and objective measures. J. Gerontol. B. Psychol. Sci. Soc. Sci. 56(2), P78-P84 (2001).
13. Teri L, Truax P. Assessment of depression in dementia patients: association of caregiver mood with depression ratings. Gerontologist 34(2), 231-234 (1994).
14. Rosenberg PB, Mielke MM, Lyketsos CG. Caregiver assessment of patients' depression in Alzheimer disease: longitudinal analysis in a drug treatment study. Am. J. Geriatr. Psychiatry 13, 822-826 (2005).
15. Li YS, Meyer JS, Thornby J. Longitudinal follow-up of depressive symptoms among normal versus cognitively impaired elderly. Int. J. Geriatr. Psychiatry 16(7), 718-727 (2001).
16. Zubenko GS, Zubenko WN, McPherson S, Spoor E, Marin DB, Farlow MR. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease. Am. J. Psych. 160, 857-866 (2003).
17. Lyketsos CG, Lee HB. Diagnosis and treatment of depression in Alzheimer's disease. A practical update for the clinician. Dement. Geriatr. Cogn. Disord. 17(1-2), 55-64 (2004).
18. Lyketsos CG, Sheppard JM, Steinberg M, Tschanz JA, Norton MC, Steffens DC. Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study. Int. J. Geriatr. Psychiatry 16(11), 1043-1053 (2001).
19. Rosenberg PB, Onyike CU, Katz IR, Porsteinsson AP, Mintzer JE, Schneider LS. Clinical application of operationalized criteria for 'depression of Alzheimer's disease'. Int. J. Geriatr. Psychiatry 20(2), 119-127 (2005).
20. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. 'Vascular depression' hypothesis. Arch. Gen. Psych. 54(10), 915-922 (1997).
21. Geda YE, Knopman DS, Mrazek DA. Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a propsective cohort study. Arch. Neurol. 63, 435-440 (2006).
22. Jorm AF. History of depression as a risk factor for dementia: an updated review. Aust. NZJ Psychiatry 35(6), 776-781 (2001).
23. Olin JT, Schneider LS, Katz IR, Meyers BS, Alexopoulos GS, Breitner JC. Provisional diagnostic criteria for depression of Alzheimer disease. Am. J. Geriatr. Psychiatry 10(2), 125-128 (2002).
24. Starkstein SE, Mizrahi R, Garau LM. Specificity of symptoms of depression in Alzheimer disease: a longitudinal analysis. Am. J. Geriatr. Psychiatry 13, 803-807 (2005).
25. Starkstein SE, Jorge R, Mizrahi R, Robinson RG. The construct of minor and major depression in Alzheimer's disease. Am. J. Psych. 162, 2086-2093 (2005).
26. Migliorelli R, Teson A, Sabe L, Petrachi M, Leiguarda R, Starkstein SE. Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease. Am. J. Psych. 152, 37-44 (1995).
27. Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am. J. Psych. 157(5), 708-714 (2000).
28. Steinberg M, Munro CA, Samus Q, Brandt J, Lyketsos CG. Patient predictors of response to treatment of depression in Alzheimer's disease: the DIADS study. Int. J. Geriatr. Psychiatry 19(2), 144-150 (2004).
29. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer's disease III: disorders of mood. Br. J. Psych. 157, 81-86 (1990).
30. Aalten P, de Vugt ME, Jaspers N, Jolles J, Verhey FR. The course of neuropsychiatric symptoms in dementia. Part I: findings from the two-year longitudinal Maasbed study. Int. J. Geriatr. Psychiatry 20(6), 523-530 (2005).
31. Aalten P, de Vugt ME, Jaspers N, Jolles J, Verhey FR. The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural subsyndromes and the influence of clinical variables. Int. J. Geriatr. Psychiatry 20(6), 531-536 (2005).
32. Starkstein SE, Chemerinski E, Sabe L, Kuzis G, Petracca G, Teson A. Prospective longitudinal study of depression and anosognosia in Alzheimer's disease. Br. J. Psych. 171, 47-52 (1997).
33. Garre-Olmo J, Lopez-Pousa S, Vilalta-Franch J, Turon-Estrada A, Hernandez-Ferrandiz M, Lozano-Gallego M. Evolution of depressive symptoms in Alzheimer disease: one-year follow-up. Alzheimer. Dis. Assoc. Disord. 17(2), 77-85 (2003).
34. Reifler BV, Teri L, Raskind M, Veith R, Barnes R, White E. Double-blind trial of imipramine in Alzheimer's disease patients with and without depression. Am. J. Psych. 146(1), 45-49 (1989).
35. Fuchs A, Hehnke U, Erhart C, Schell C, Pramshohler B, Danninger B. Video rating analysis of effect of maprotiline in patients with dementia and depression. J. Psychopharmacol ogy 26(2), 37-41 (1993).
36. Petracca G, Teson A, Chemerinski E, Leiguarda R, Starkstein SE. A doubleblind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease. J. Neuropsych. Clin. Neurosci. 8(3), 270-275 (1996).
37. Nyth AL, Gottfries CG. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study. Br. J. Psych. 157, 894-901 (1990).
38. Nyth AL, Gottfries CG, Lyby K, Smedegaard-Andersen L, Gylding-Sabroe J, Kristensen M. A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatrica. Scandinavica 86(2), 138-145 (1992).
39. Petracca GM, Chemerinski E, Starkstein SE. A double-blind, placebocontrolled study of fluoxetine in depressed patients with Alzheimer's disease. Int. Psychogeriatrics 13(2), 233-240 (2001).
40. Lyketsos CG, Sheppard JM, Steele CD, Kopunek S, Steinberg M, Baker AS. Randomized, placebo-controlled, doubleblind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study. Am. J. Psych. 157(10), 1686-1689 (2000).
41. Magai C, Kennedy G, Cohen CI, Gomberg D. A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease. Am. J. Geriatr. Psychiatry 8(1), 66-74 (2000).
42. Taragano FE, Lyketsos CG, Mangone CA, Allegri RF, Comesana-Diaz E. A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer's disease. Psychosomatics 38(3), 246-252 (1997).
43. Katona CL, Hunter BN, Bray J. A doubleblind comparison of the efficacy and safely of paroxetine and imipramine in the treatment of depression with dementia. Int. J. Geriatr. Psychiatry 13(2), 100-108 (1998).
44. Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, Munro C. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Arch. Gen. Psych. 60(7), 737-746 (2003).
45. Roth M, Mountjoy CQ, Amrein R. Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebocontrolled trial. Br. J. Psych. 168(2), 149-157 (1996).
46. Teri L, Logsdon RG, Uomoto J, McCurry SM. Behavioral treatment of depression in dementia patients: a controlled clinical trial. J. Gerontol. B Psychol. Sci. Soc. Sci. 52(4), P159-P166 (1997).
47. Livingston G, Johnston K, Katona CL, Paton J, Lyketsos CG. Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. Am. J. Psych. 162, 1996-2021 (2005).
48. Nelson J, Rosenberg D. ECT treatment of demented elderly patients with major depression: a retrospective study of efficacy and safety. Convulsive Therapy 7, 157-165 (1991).
49. Rao V, Lyketsos CG. The benefits and risks of ECT for patients with primary dementia who also suffer from depression. Int. J. Geriatr. Psychiatry 15(8), 729-735 (2000).